Healthcare Services

Viral Hepatitis Industry Expansion Forecast Showing Market Size of $20.84 Billion by 2030 at 4.7% CAGR

April 7, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Viral Hepatitis Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The viral hepatitis market size has demonstrated consistent expansion over recent years. It is projected to increase from $16.77 billion in 2025 to $17.37 billion in 2026, growing at a compound annual growth rate (CAGR) of 3.6%. This historical expansion can be attributed to improvements in blood screening practices, the expansion of vaccination coverage, the availability of antiviral medications, increased disease awareness, and the establishment of public health hepatitis programs.

The viral hepatitis market size is projected for consistent expansion in the next few years, set to reach $20.85 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 4.7%. This anticipated growth during the forecast period can be attributed to an increasing focus on hepatitis elimination initiatives, rising investments in novel antiviral drugs, the expansion of point-of-care diagnostics, the growing adoption of combination therapies, and increasing global screening programs. Major trends throughout the forecast period include the increasing adoption of advanced antiviral therapies, a rising use of molecular diagnostic techniques, a growing focus on early disease detection, the expansion of vaccination programs, and enhanced monitoring of chronic hepatitis cases.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13028&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Viral Hepatitis Market?

An escalating occurrence of hepatitis is anticipated to drive the expansion of the viral hepatitis market going forward. Hepatitis is characterized as a liver infection originating from various infectious viruses and non-infectious substances, which can lead to multiple medical conditions. Among the viruses capable of causing viral hepatitis, resulting in liver inflammation and damage, are Hepatitis A, B, C, D, and E. For instance, in April 2025, data from the European Centre for Disease Prevention and Control (ECDC), a Sweden-based European Union (EU) health agency, showed that in 2023, 30 EU/EEA Member States reported 37,766 newly diagnosed cases of hepatitis B virus (HBV) infection, corresponding to a crude rate of 8.1 cases per 100 000 population. Therefore, the increasing prevalence of hepatitis will stimulate the viral hepatitis market.

What Major Segment Divisions Exist Within The Viral Hepatitis Market?

The viral hepatitis market covered in this report is segmented –

1) By Disease Type: Hepatitis A, Hepatitis B, Hepatitis C, Other Disease Types

2) By Diagnosis: Liver Biopsy, Blood Tests, Imaging Tests, Other Diagnosis

3) By Treatment: Antiviral Drugs, Surgery, Vaccine, Immune Modulator Drugs, Other Treatments

4) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Hepatitis A: Acute Hepatitis A, Chronic Hepatitis A

2) By Hepatitis B: Acute Hepatitis B, Chronic Hepatitis B, Hepatitis B Carrier

3) By Hepatitis C: Acute Hepatitis C, Chronic Hepatitis C

4) By Other Disease Types: Hepatitis D, Hepatitis E

How Are Trends Shaping The Direction Of The Viral Hepatitis Market?

Leading companies within the viral hepatitis market are concentrating on integrating sophisticated immunoassay technologies, specifically automated, dual-marker immunoassays, to improve early detection and tracking of the disease. These automated, dual-marker immunoassays are in-vitro diagnostic tools capable of simultaneously identifying both antigen and antibody from a single sample. This functionality facilitates advantages like near-real-time assessment of infection status, a reduced diagnostic window, and enhanced screening capacity. As an illustration, in July 2023, Roche Diagnostics India, an India-based supplier of in-vitro diagnostics and laboratory automation solutions, introduced Elecsys HCV Duo. This dual-antigen and antibody immunoassay targets the detection of hepatitis C virus by independently identifying HCV core antigen and anti-HCV antibodies concurrently from a single serum or plasma sample. It enables a significantly earlier diagnosis of active HCV infection and is compatible with automated analyzer platforms such as cobas e 402 and e 801. The Elecsys HCV Duo contributes to better early detection, quicker connection to care, optimized diagnostic procedures, and a decrease in the strain on healthcare systems.

Which Companies Are Leading Innovation In The Viral Hepatitis Market?

Major companies operating in the viral hepatitis market are Pfizer Inc., Johnson & Johnson Co, F Hoffmann-La Roche AG, Merck & Co., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Hetero Drugs Ltd., Eisai Co. Ltd., Boehringer Ingelheim Group, Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr. Reddy’s Laboratories, Zydus Lifescience Ltd., Glenmark Pharmaceuticals Ltd., Cipla Ltd., Torrent Pharmaceuticals Ltd., Otsuka Pharmaceutical Co. Ltd., Wockhardt Ltd.

Read the full viral hepatitis market report here:

https://www.thebusinessresearchcompany.com/report/viral-hepatitis-global-market-report

What Are The Leading Geographic Regions In The Viral Hepatitis Market?

North America was the largest region in the viral hepatitis market in 2025. The regions covered in the viral hepatitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Viral Hepatitis Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13028&type=smp

Browse Through More Reports Similar to the Global Viral Hepatitis Market 2026, By The Business Research Company

Hepatitis Drugs Global Market Report

https://www.thebusinessresearchcompany.com/report/hepatitis-drugs-global-market-report

Hepatitis Therapeutics Global Market Report

https://www.thebusinessresearchcompany.com/report/hepatitis-therapeutics-global-market-report

Hepatitis C Global Market Report

https://www.thebusinessresearchcompany.com/report/hepatitis-c-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795